Literature DB >> 32242748

Qualitative analysis of contrast-enhanced ultrasound in the diagnosis of small, TR3-5 benign and malignant thyroid nodules measuring ≤1 cm.

Xin Li1, Feng Gao1, Fan Li1, Xiao-Xia Han1, Si-Hui Shao1, Ming-Hua Yao1, Chun-Xiao Li1, Jun Zheng2, Rong Wu1, Lian-Fang Du1.   

Abstract

OBJECTIVE: To evaluate the performance of contrast-enhanced ultrasound in the diagnosis of small, solid, TR3-5 benign and malignant thyroid nodules (≤1 cm).
METHODS: From January 2016 to March 2018, 185 thyroid nodules from 154 patients who underwent contrast enhanced ultrasound (CEUS) and fine-needle aspiration or thyroidectomy in Shanghai General Hospital were included. The χ2 test was used to compare the CEUS characteristics of benign and malignant thyroid nodules, and the CEUS features of malignant nodules assigned scores. The total score of the CEUS features and the scores of the above nodules were evaluated according to the latest 2017 version of the Thyroid Imaging Reporting and Data System (TI-RADS). The diagnostic performance of the two were compared based on the receiver operating characteristic curves generated for benign and malignant thyroid nodules.
RESULTS: The degree, enhancement patterns, boundary, shape, and homogeneity of enhancement in thyroid small solid nodules were significantly different (p<0.05). No significant differences were seen between benign and malignant thyroid nodules regarding completeness of enhancement and size of enhanced lesions (p>0.05). The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of the TI-RADS classification TR5 in diagnosis of malignant nodules were 90.10%, 55.95%, 74.59%, 72.22%, and 82.46%, respectively (area under the curve [AUC]=0.738; 95% confidence interval[CI], 0.663-0.813). The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of the total score of CEUS qualitative analysis indicators were 86.13%, 89.29%, 87.57%, 90.63%, and 84.27% respectively (AUC = 0.916; 95% CI, 0.871-0.961).
CONCLUSION: CEUS qualitative analysis is superior to TI-RADS in evaluating the diagnostic performance of small, solid thyroid nodules. Qualitative analysis of CEUS has a significantly higher specificity for diagnosis of malignant thyroid nodules than TI-RADS. ADVANCES IN KNOWLEDGE: The 2017 version of TI-RADS has recently suggested the malignant stratification of thyroid nodules by ultrasound. In this paper we applied this system and CEUS to evaluate 185 nodules and compare the results with pathological findings to access the diagnostic performance.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32242748      PMCID: PMC7336072          DOI: 10.1259/bjr.20190923

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  28 in total

1.  Quantitative evaluation of contrast-enhanced ultrasound after intravenous administration of a microbubble contrast agent for differentiation of benign and malignant thyroid nodules: assessment of diagnostic accuracy.

Authors:  Ursula Nemec; Stefan F Nemec; Clemens Novotny; Michael Weber; Christian Czerny; Christian R Krestan
Journal:  Eur Radiol       Date:  2012-02-10       Impact factor: 5.315

2.  Assessment of the American College of Radiology Thyroid Imaging Reporting and Data System for Thyroid Nodule Malignancy Risk Stratification in a Pediatric Population.

Authors:  Jennifer E Lim-Dunham; Iclal Erdem Toslak; Michael P Reiter; Brendan Martin
Journal:  AJR Am J Roentgenol       Date:  2018-11-07       Impact factor: 3.959

3.  Risk Factors of Metastatic Lymph Nodes in Papillary Thyroid Microcarcinoma.

Authors:  José Ruiz Pardo; Antonio Ríos; José M Rodríguez; Miriam Paredes; Víctor Soriano; María I Oviedo; Antonio M Hernández; Pascual Parrilla
Journal:  Cir Esp (Engl Ed)       Date:  2020-01-21

4.  Role of Contrast-Enhanced Ultrasound in Diagnosis of Thyroid Nodules in Acoustic Radiation Force Impulse "Gray Zone".

Authors:  Jia Zhan; Xue-Hong Diao; Lin Chen; Jia-Mei Jin; Yue Chen
Journal:  Ultrasound Med Biol       Date:  2017-04-19       Impact factor: 2.998

5.  Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS.

Authors:  M Claudon; C F Dietrich; B I Choi; D O Cosgrove; M Kudo; C P Nolsøe; F Piscaglia; S R Wilson; R G Barr; M C Chammas; N G Chaubal; M-H Chen; D A Clevert; J M Correas; H Ding; F Forsberg; J B Fowlkes; R N Gibson; B B Goldberg; N Lassau; E L S Leen; R F Mattrey; F Moriyasu; L Solbiati; H-P Weskott; H-X Xu
Journal:  Ultraschall Med       Date:  2012-11-05       Impact factor: 6.548

6.  Routine central compartment lymph node dissection for patients with papillary thyroid carcinoma.

Authors:  David I Kutler; Audrey D Crummey; William I Kuhel
Journal:  Head Neck       Date:  2011-03-17       Impact factor: 3.147

7.  Ultrasonography-guided fine-needle aspiration of thyroid incidentaloma: correlation with pathological findings.

Authors:  Il Seong Nam-Goong; Ha Young Kim; Gyungyub Gong; Ho Kyu Lee; Suck Joon Hong; Won Bae Kim; Young Kee Shong
Journal:  Clin Endocrinol (Oxf)       Date:  2004-01       Impact factor: 3.478

8.  Three-dimensional reconstruction of vessel distribution in benign and malignant lesions of thyroid.

Authors:  Maria P Foschini; Mauro Papotti; Alfredo Parmeggiani; Giovanni Tallini; Luciano Castaldini; Domenico Meringolo; Vincenzo Eusebi
Journal:  Virchows Arch       Date:  2004-06-08       Impact factor: 4.064

9.  Contrast-enhanced ultrasound in the characterisation of breast masses: utility of quantitative analysis in comparison with MRI.

Authors:  Natalia Caproni; Francesca Marchisio; Annarita Pecchi; Barbara Canossi; Rachele Battista; Piero D'Alimonte; Pietro Torricelli
Journal:  Eur Radiol       Date:  2009-12-22       Impact factor: 5.315

10.  Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma.

Authors:  Y Luo; Y Zhao; K Chen; J Shen; J Shi; S Lu; J Lei; Z Li; D Luo
Journal:  J Endocrinol Invest       Date:  2018-06-06       Impact factor: 4.256

View more
  3 in total

1.  Contrast-enhanced ultrasound improves the potency of fine-needle aspiration in thyroid nodules with high inadequate risk.

Authors:  Tinghui Yin; Bowen Zheng; Yufan Lian; Haifeng Li; Lei Tan; Shicheng Xu; Yong Liu; Tao Wu; Jie Ren
Journal:  BMC Med Imaging       Date:  2022-05-02       Impact factor: 2.795

2.  Clinical Application of C-TIRADS Category and Contrast-Enhanced Ultrasound in Differential Diagnosis of Solid Thyroid Nodules Measuring ≥1 cm.

Authors:  Zhuang Jin; Yaqiong Zhu; Yu Lei; Xin Yu; Nan Jiang; Yue Gao; Junying Cao
Journal:  Med Sci Monit       Date:  2022-06-07

3.  Contrast-Enhanced Ultrasound: An Effective Method for Noninvasive Diagnosis of Mummified Thyroid Nodules.

Authors:  Hong Zhang; Xiaoqu Tan; Linxue Qian
Journal:  Int J Endocrinol       Date:  2022-04-27       Impact factor: 2.803

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.